{
    "code": "52027995",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027995",
    "time": "2021-01-22 04:36:52",
    "許可證字號": "衛部藥輸字第027995號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/12\/23",
    "發證日期": "109\/12\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202799502",
    "中文品名": "愛克利150毫克膜衣錠",
    "英文品名": "PIQRAY 150 mg Film-Coated Tablets",
    "適應症": "與fulvestrant併用可治療患有荷爾蒙受體(HR)陽性、第二型人類表皮生長因子受體(HER2)陰性及PIK3CA突變的局部晚期或轉移性乳癌，且曾接受內分泌治療但疾病惡化的停經後女性及男性病人。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠PVC\/PCTFE塑膠泡殼鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/12\/23",
    "主成分略述": "alpelisib",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FSI0004000  LEK PHARMACEUTICALS D.D., SLOVENIA",
            "製造廠廠址": "VEROVSKOVA 57, SI-1526 LJUBLJANA, SLOVENIA",
            "製造廠公司地址": "",
            "製造廠國別": "SLOVENIA",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013008500",
            "成分名稱": "alpelisib",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PIQRAY_嚴重皮膚反應_醫療人員衛教單張-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=004&Type=9"
        },
        {
            "title": "PIQRAY_嚴重皮膚反應_病人衛教單張-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=003&Type=9"
        },
        {
            "title": "PIQRAY_藥品組合包裝_病人用藥衛教單張-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=002&Type=9"
        },
        {
            "title": "PIQRAY_TWI-021220_仿單-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=001&Type=9"
        },
        {
            "title": "PIQRAY_300mg daily dose_鋁箔 (150mg)-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=004&Type=8"
        },
        {
            "title": "PIQRAY_300mg daily dose_標籤 (150mg)-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=003&Type=8"
        },
        {
            "title": "PIQRAY_300mg daily dose_外盒 (150mg, 28天)-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=002&Type=8"
        },
        {
            "title": "PIQRAY_300mg daily dose_外盒 (150mg, 14天)-109-12-31.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027995&Seq=001&Type=8"
        }
    ]
}